| CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC X Yuan, X Hao, HL Chan, N Zhao, DA Pedroza, F Liu, K Le, AJ Smith, ... bioRxiv, 2024 | | 2024 |
| CSF-1R antibody targeting therapy with combined metronomic chemotherapy and immune checkpoint blockade enhance a B and T cell response to attenuate metastatic triple negative … DA Pedroza, Q Zhu, W Wu, P Porter, XHF Zhang, JM Rosen CANCER RESEARCH 84 (3), 2024 | | 2024 |
| Abstract PR03: CSF-1R antibody targeting therapy with combined metronomic chemotherapy and immune checkpoint blockade enhance a B and T cell response to attenuate metastatic … DA Pedroza, Q Zhu, W Wu, P Porter, XHF Zhang, JM Rosen Cancer Research 84 (3_Supplement_1), PR03-PR03, 2024 | | 2024 |
| Abstract IA05: Leveraging preclinical models of triple negative breast cancer for translational research JM Rosen, D Pedroza, N Zhao, XHF Zhang, CM Perou Cancer Research 84 (3_Supplement_1), IA05-IA05, 2024 | | 2024 |
| Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer N Zhao, EB Kabotyanski, AB Saltzman, A Malovannaya, X Yuan, ... The Journal of clinical investigation 133 (24), 2023 | 5 | 2023 |
| Tumor concentration of metformin is a determinant factor of its regulation of fatty acid β-oxidation and c-Src pathway in triple-negative breast cancer J Park, KH Jung, D Jia, S Yang, KS Attri, S Ahn, D Murthy, M Ghidey, ... Cancer Research 83 (7_Supplement), 294-294, 2023 | | 2023 |
| Abstract PD2-05: CSF-1R antibody targeting therapy with combined metronomic chemotherapy enhances a B and T cell response for the treatment of metastatic triple negative breast … D Pedroza, W Wu, P Porter, X Zhang, J Rosen Cancer Research 83 (5_Supplement), PD2-05-PD2-05, 2023 | | 2023 |
| Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer S Singh, N Lee, DA Pedroza, IL Bado, C Hamor, L Zhang, S Aguirre, J Hu, ... Cancer research 82 (12), 2281-2297, 2022 | 31 | 2022 |
| Nantong University, China Background: Increased expression of the progesterone receptor membrane component 1, a heme and progesterone binding protein, is frequently found in … R Lakshmanaswamy, DA Pedroza, M Ramirez, V Rajamanickam, ... Non-coding RNAs in Breast Cancer, 710337123, 2022 | | 2022 |
| miRNome and Functional Network Analysis of PGRMC1 regulated miRNA target genes identify pathways and Biological functions Associated with Triple negative breast Cancer DA Pedroza, M Ramirez, V Rajamanickam, R Subramani, V Margolis, ... Frontiers in Oncology 11, 710337, 2021 | 4 | 2021 |
| Pregnancy Inhibits Mammary Carcinogenesis by Persistently Altering the Hypothalamic–Pituitary Axis R Subramani, A Estrada, M Dixon, M Parada, S Rodriguez, DA Pedroza, ... Cancers 13 (13), 3207, 2021 | 3 | 2021 |
| Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation DA Pedroza, R Subramani, K Tiula, A Do, N Rashiraj, A Galvez, ... Laboratory Investigation 101 (6), 733-744, 2021 | 30 | 2021 |
| Chemotherapy coupled to macrophage inhibition leads to enhanced T and B cell infiltration and durable triple negative breast cancer regression S Singh, N Lee, DA Pedroza, I Bado, L Zhang, S Aguirre, C Hamor, ... bioRxiv, 2021.02. 22.432300, 2021 | | 2021 |
| Synergy of chemotherapy and macrophage depletion leads to T cell memory activation and durable triple negative breast cancer regression S Singh, N Lee, I Bado, C Hamor, L Zhang, S Aguirre, J Hu, Y Shen, Y Xu, ... bioRxiv, 2021 | 2 | 2021 |
| Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis R Subramani, J Medel, K Flores, C Perry, A Galvez, M Sandoval, S Rivera, ... Scientific Reports 10 (1), 20225, 2020 | 7 | 2020 |
| Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling DA Pedroza, V Rajamanickam, R Subramani, A Bencomo, A Galvez, ... British journal of cancer 123 (8), 1326-1335, 2020 | 50 | 2020 |
| Classical and non-classical progesterone signaling in breast cancers DA Pedroza, R Subramani, R Lakshmanaswamy Cancers 12 (9), 2440, 2020 | 34 | 2020 |
| Abstract P1-12-02: Growth hormone and prolactin influences mammary epithelial and stromal interactions in early parity induced protection against breast cancer R Subramani, A Galvez, D Pedroza, A Bencomo, M Dixon, ... Cancer Research 80 (4_Supplement), P1-12-02-P1-12-02, 2020 | | 2020 |
| Abstract P6-05-08: Progesterone receptor membrane component 1 controls cellular proliferation and plays a key role in the molecular circuitry of both ER positive and triple … DA Pedroza, A Bencomo, A Galvez, R Subramani, V Rajamanickam, ... Cancer Research 80 (4_Supplement), P6-05-08-P6-05-08, 2020 | | 2020 |
| Growth hormone and prolactin influences mammary epithelial and stromal interactions in early parity induced protection against breast cancer R Subramani, A Galvez, D Pedroza, A Bencomo, M Dixon, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
